CD14+ monocytes promote the immunosuppressive effect of human umbilical cord matrix stem cells (Q39879492)

15 September 2017

title

CD14+ monocytes promote the immunosuppressive effect of human umbilical cord matrix stem cells (English)

1 reference

15 September 2017

Ding Wang

1

1 reference

15 September 2017

Ke Chen

2

1 reference

15 September 2017

Wei Ting Du

3

1 reference

15 September 2017

Zhi-Bo Han

4

1 reference

15 September 2017

He Ren

5

1 reference

15 September 2017

Ying Chi

6

1 reference

15 September 2017

Shao Guang Yang

7

1 reference

15 September 2017

Francis Bayard

8

1 reference

15 September 2017

Delin Zhu

9

1 reference

15 September 2017

Zhong Chao Han

10

1 reference

15 September 2017

language of work or name

English

0 references

publication date

24 April 2010

1 reference

Experimental Cell Research

15 September 2017

published in

1 reference

15 September 2017

volume

316

1 reference

15 September 2017

issue

15

1 reference

15 September 2017

page(s)

2414-2423

1 reference

Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Human mesenchymal stem cells modulate allogeneic immune cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Differentiation of human umbilical cord mesenchymal stromal cells into low immunogenic hepatocyte-like cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Cografted Wharton's jelly cells-derived neurospheres and BDNF promote functional recovery after rat spinal cord transection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Immune properties of human umbilical cord Wharton's jelly-derived cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Immunogenicity of umbilical cord tissue derived cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

IFN-γ and TNF-α differentially regulate immunomodulation by murine mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Adult mesenchymal stem cells: a pluripotent population with multiple applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Multipotent mesenchymal stromal cells and immune tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Prostaglandin E2 inhibits T cell activation-induced apoptosis and Fas-mediated cellular cytotoxicity by blockade of Fas-ligand induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

EP4 mediates PGE2 dependent cell survival through the PI3 kinase/AKT pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

Immunological and inflammatory functions of the interleukin-1 family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.04.018

10.1016/J.YEXCR.2010.04.018

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference